相关实验视频
Updated: Jun 6, 2025

08:01
The Soft Agar Colony Formation Assay
Published on: October 27, 2014
111.4K
奇胺和维尼托克拉克斯通过MYCN/DKK3协同调节B-ALL中的Wnt/β-catenin通路
Linlin Zhao1, Lili Sun2, Desheng Kong3
1Department of Blood Transfusion, The First Affiliated Hospital, Harbin Medical University, Harbin, China.
Annals of hematology
|November 28, 2024
概括
基胺,一个组织素脱乙酶抑制剂,和venetoclax,一个BCL2抑制剂,在治疗B细胞急性淋巴细胞白血病 (B-ALL) 中表现出协同作用. 这种组合疗法针对关键路径,为B-ALL患者提供了一种新的策略.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 由于药物耐药性和复发,B细胞急性淋巴细胞白血病 (B-ALL) 仍然是一个挑战.
- 目前的治疗方法虽然有所改善,但对一些成人B-ALL患者的长期存活有局限性.
研究的目的:
- 研究基达胺 (HDAC抑制剂) 和维内托克拉克斯 (BCL2抑制剂) 在B-ALL中的协同作用.
- 探索这种组合对Wnt/β-catenin信号通路及其组件 (MYCN, DKK3) 的影响.
主要方法:
- 进行了体外和体内实验.
- 这项研究评估了素脱乙酶 (HDAC) 和BCL2活性的抑制.
- 评估了MYCN和DKK3表达和Wnt/β-catenin信号的变化.
主要成果:
- 奇胺和venetoclax证明了MYCN表达的协同抑制和DKK3表达的增加.
- 组合疗法有效抑制了Wnt/β-catenin信号通路.
- 在体外和体外模型中观察到B-ALL细胞增殖的显著抑制.
结论:
- 奇达胺和venetoclax的组合为B-ALL提供了一个有前途的新治疗策略.
- 这种方法针对涉及B-ALL进展和扩散的关键分子通路.
- 对这种组合疗法的进一步研究可能会改善B-ALL患者的治疗结果.
相关概念视频
Canonical Wnt Signaling Pathway
8.7K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K
Non-Canonical Wnt Signaling Pathways
7.2K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.2K
Catenins
2.3K
Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
2.3K
Anaphase Promoting Complex
2.8K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.8K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K

